Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD.
about
Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Randomized, double-blind, plac ...... with moderate-to-severe COPD.
@en
Randomized, double-blind, plac ...... with moderate-to-severe COPD.
@nl
type
label
Randomized, double-blind, plac ...... with moderate-to-severe COPD.
@en
Randomized, double-blind, plac ...... with moderate-to-severe COPD.
@nl
prefLabel
Randomized, double-blind, plac ...... with moderate-to-severe COPD.
@en
Randomized, double-blind, plac ...... with moderate-to-severe COPD.
@nl
P2093
P2860
P356
P1476
Randomized, double-blind, plac ...... with moderate-to-severe COPD.
@en
P2093
Andrea Maes
Colin Reisner
Earl St Rose
Hisakuni Sekino
Shahid Siddiqui
Yasushi Fukushima
Yuji Nakatani
Yumiko Ide
P2860
P304
P356
10.2147/COPD.S159246
P407
P577
2018-04-13T00:00:00Z